A Hit and a Miss for Liquid Biopsy to Guide Adjuvant Cancer Therapy

(MedPage Today) — BERLIN — Survival in high-risk bladder cancer improved significantly with use of circulating tumor (ct)DNA to guide adjuvant treatment in patients who tested positive after surgery, the randomized, placebo-controlled IMvigor011…

Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118072

Author :

Publish date : 2025-10-21 21:36:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

A Hit and a Miss for Liquid Biopsy to Guide Adjuvant Cancer Therapy

Immunizing Both Mom and Baby Against RSV Appears Effective, Safe

What Americans Think About Rising Healthcare Costs, According to a New AP-NORC Poll

Related Posts

AI Hybrid Model With Human Scribe May Cut Physician Burden

User Engagement in a Weight-Loss App Boosts GLP-1 Success

Higher proportion now contacting GPs in England online, figures show

Exposure to Some DMARDs in Fathers-to-Be Tied to Birth Risks

Government racks up £100m bill responding to Covid inquiry

Study Finds Significant Number of Breast Cancers in Women Under 40

AI Hybrid Model With Human Scribe May Cut Physician Burden

User Engagement in a Weight-Loss App Boosts GLP-1 Success

Higher proportion now contacting GPs in England online, figures show

Exposure to Some DMARDs in Fathers-to-Be Tied to Birth Risks

Government racks up £100m bill responding to Covid inquiry

Study Finds Significant Number of Breast Cancers in Women Under 40

HHS Officially Rescinds Nursing Home Minimum Staffing Rule

Supreme Court Likely to Side With Abortion Opponents in State Investigation Dispute

Categories

Archives